Data / Form D filings / Beech Tree Labs, Inc.
Beech Tree Labs, Inc.: Form D filings
Beech Tree Labs, Inc., a biotechnology company in Delanson, NY, filed 4 Form D notices with the SEC between 2010 and 2015. The latest, on September 25, 2015, reports $124,992 sold of a $6 million offering to 2 investors.
Find out what Beech Tree Labs, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 545 WESTFALL ROAD, Delanson, NY, 12053
- Phone
- (518) 872-1144
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1487123
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 25, 2015 | New notice | $6,000,000 | $124,992 | $5,875,008 | 2 | Sep 11, 2015 | sec.gov |
| Nov 7, 2012 | Amendment | $7,000,000 | $5,820,795 | $1,179,205 | 31 | Oct 27, 2011 | sec.gov |
| Nov 8, 2011 | New notice | $5,000,000 | $125,000 | $4,875,000 | 1 | Oct 27, 2011 | sec.gov |
| Mar 15, 2010 | New notice | $6,000,000 | $1,461,591 | $4,538,409 | 25 | Sep 16, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Arthur de Witt Ackerman | Director | |
| John McMichael | Executive Officer, Director | |
| Robert I. Kramer | Director | |
| Thomas A. Hatch | Executive Officer | |
| John I. Glasson | Director | |
| John A. Ross | Director | |
| Jeffrey A. Eckmann | Director | |
| William de Witt Ryan | Director | |
| H.W. I. McKay Belk | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Sep 21, 2015 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Beech Tree Labs, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.